Skip to main content

Table 2 Laboratory variables at baseline and after beginning of pUFa

From: Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients

 

Pre-pUFa

Post-pUFa

 

3 months

P

6 months

P

12 months

P

Last follow- up

P

hs TNTd (pg/ml)

 HFrEFb

108.0 ± 233.1

77.5 ± 58.7

0.189

136.3 ± 184.7

0.608

105.6 ± 79.5

0.046

107.3 ± 39.0

0.949

 HFpEF

152.0 ± 236.5

124.3 ± 12.4

0.586

150.0 ± 198.0

0.410

123.3 ± 57.5

0.848

177.5 ± 101.4

0.665

NT proBNP (pg/ml)

 HFrEFb

5220.1 ± 4438.4

4944.7 ± 10,351.8

0.404

5242.6 ± 8465.3

0.542

3539.6 ± 5776.2

0.309

6650.0 ± 11,197.5

0.148

 HFpEF

2630.3 ± 2029.7

1980.0 ± 2309.6

0.323

2033.9 ± 2701.2

0.645

2059.0 ± 3218.6

0.937

2407.0 ± 5296.6

0.495

Albumin (g/l)

 HFrEFb

38.6 ± 5.59

37.8 ± 5.76

0.200

38.0 ± 7.65

0.140

38.9 ± 4.89

0.509

37.9 ± 7.43

0.166

 HFpEF

38.0 ± 6.64

35.5 ± 7.73

0.147

36.4 ± 3.91

0.884

39.8 ± 3.27

0.309

35.4 ± 5.54

0.187

Creatinine (mg/dl)

 HFrEFb

3.19 ± 3.12

3.14 ± 2.62

0.717

3.49 ± 2.67

0.959

3.30 ± 2.82

0.133

3.90 ± 2.98

0.090

 HFpEFc

2.65 ± 1.29

2.96 ± 1.62

0.220

3.32 ± 1.97

0.008

3.77 ± 2.29

0.018

4.00 ± 2.15

0.008

MDRDe eGFRf (ml/min/1.73 m2)

 HFrEFb

23.1 ± 10.6

28.4 ± 18.3

0.240

25.9 ± 14.8

0.351

26.3 ± 14.6

0.620

23.3 ± 19.8

0.841

 HFpEFc

27.8 ± 13.2

26.5 ± 15.1

0.628

27.4 ± 17.4

0.530

23.3 ± 15.2

0.094

19.5 ± 15.4

0.042

BUN (mg/dl)

 HFrEFb

145.4 ± 68.0

109.2 ± 84.7

<  0.001

103.0 ± 42.5

<  0.001

94.1 ± 37.4

<  0.001

102.9 ± 42.1

<  0.001

 HFpEFc

153.5 ± 69.2

94.6 ± 32.5

0.011

101.4 ± 39.8

0.015

105.6 ± 45.4

0.070

117.3 ± 48.8

0.117

CRP (mg/l)

 HFrEFb

37.9 ± 59.0

14.4 ± 29.4

0.002

9.90 ± 12.5

0.002

8.67 ± 8.36

0.011

17.3 ± 27.6

0.009

 HFpEFc

19.4 ± 17.6

6.56 ± 7.93

0.067

6.83 ± 8.16

0.069

13.3 ± 26.1

0.028

13.7 ± 21.4

0.019

Sodium (mmol/l)

 HFrEFb

136.2 ± 5.07

137.9 ± 4.88

0.025

137.1 ± 4.84

0.127

138.2 ± 4.04

0.055

136.6 ± 5.31

0.992

 HFpEFc

137.2 ± 3.85

137.4 ± 10.1

0.602

138.3 ± 5.30

0.821

136.9 ± 5.72

0.336

137.1 ± 6.47

0.089

Potassium (mmol/l)

 HFrEFb

4.32 ± 0.74

4.22 ± 0.68

0.035

4.19 ± 0.60

0.013

4.26 ± 0.54

0.213

4.29 ± 0.85

0.217

 HFpEFc

4.25 ± 0.68

4.14 ± 0.64

0.287

4.50 ± 0.56

0.107

4.02 ± 0.50

0.340

4.36 ± 0.62

0.756

Phosphate (mmol/l)

 HFrEFb

1.47 ± 0.51

1.47 ± 0.65

0.984

1.59 ± 0.78

0.771

1.61 ± 0.97

0.315

1.67 ± 1.16

0.146

 HFpEFc

1.86 ± 1.98

1.72 ± 1.14

0.276

1.54 ± 0.51

0.428

1.37 ± 0.30

0.470

1.86 ± 1.56

0.388

Haemoglobin (mg/dl)

 HFrEFb

11.3 ± 1.74

11.9 ± 1.71

0.024

11.7 ± 2.20

0.030

12.6 ± 1.79

<  0.001

11.6 ± 2.09

0.614

 HFpEFc

10.8 ± 1.68

11.7 ± 2.12

0.038

11.9 ± 2.29

0.014

11.9 ± 1.87

0.025

11.2 ± 2.40

0.105

  1. Data are presented as mean ± SD
  2. apUF (peritoneal ultrafiltration)
  3. bHFrEF (heart failure with reduced ejection fraction)
  4. cHFrEF (heart failure with preserved ejection fraction)
  5. dhsTNT (high sensitive troponin)
  6. eMDRD (modification of diet in renal disease)
  7. feGFR (estimated glomerular filtration rate)
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us